Tisdag 9 December | 14:29:46 Europe / Stockholm
Svenska | English

BioStock

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Alzinova comments on the Letter of Intent in Saudi Arabia
2025-12-09 12:25:00

Alzinova recently took a strategic step forward for ALZ-101 by entering a non-binding Letter of Intent with a leading healthcare provider in Saudi Arabia. The deal paves the way for hosting parts of the Phase II trial in the region and exploring joint development and financing for ALZ-101 and ALZ-201. Speaking to BioStock, CEO Tord Labuda explains the background, the shared benefits of the collaboration, and upcoming milestones.

Watch the interview at biostock.se:

Alzinova comments on the letter of intent in Saudi Arabia

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter 
Follow BioStock on social media: LinkedIn and Facebook!  
 
About BioStock 
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden